{
    "root": "fcfe3e97-071d-44d8-8235-bb6b67567c18",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CEREBYX",
    "value": "20250518",
    "ingredients": [
        {
            "name": "FOSPHENYTOIN SODIUM",
            "code": "7VLR55452Z",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5165"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "TROMETHAMINE",
            "code": "023C2WHX2V",
            "drugbank_id": "https://go.drugbank.com/drugs/DB03754"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        }
    ],
    "indications": {
        "text": "cerebyx indicated treatment generalized tonic-clonic status epilepticus prevention treatment seizures occurring neurosurgery . cerebyx also substituted , short-term , oral phenytoin . cerebyx used oral phenytoin possible [ ( 2.4 ) ( 5.2 ) ] .",
        "doid_entities": [
            {
                "text": "status epilepticus (DOID:1824)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1824"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 dose , concentration , infusion rate cerebyx always expressed phenytoin sodium equivalents ( pe ) ( 2.1 ) \u2022 status epilepticus : adult loading dose 15 20 mg pe/kg rate 100 150 mg pe/min ( 2.3 ) pediatric loading dose 15 20 mg pe/kg rate 2 mg pe/kg/min ( 150 mg pe/min , whichever slower ) ( 2.3 ) \u2022 non-emergent loading maintenance dosing : adult loading dose 10 20 mg pe/kg given iv im ; initial maintenance dose 4 6 mg pe/kg/day divided doses ( 2.4 ) pediatric loading dose 10 15 mg pe/kg rate 1 2 mg pe/kg/min ( 150 mg pe/min , whichever slower ) ; initial maintenance dose 2 4 mg pe/kg every 12 hours rate 1 2 mg pe/kg/min ( 100 mg pe/min , whichever slower ) ( 2.4 ) \u2022 intramuscular : cerebyx ordinarily given intramuscularly ( 2.3 , 2.4 )",
        "doid_entities": [
            {
                "text": "status epilepticus (DOID:1824)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1824"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "cerebyx contraindicated patients : \u2022a history hypersensitivity cerebyx inactive ingredients , phenytoin hydantoins [ ( 5.6 ) ] . included angioedema . \u2022sinus bradycardia , sino-atrial block , second third degree a-v block , adams-stokes syndrome effect parenteral phenytoin cerebyx ventricular automaticity . \u2022a history prior acute hepatotoxicity attributable cerebyx phenytoin [ ( 5.8 ) ] . \u2022coadministration delavirdine potential loss virologic response possible resistance delavirdine class non-nucleoside reverse transcriptase inhibitors .",
    "indications_original": "CEREBYX is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. CEREBYX can also be substituted, short-term, for oral phenytoin. CEREBYX should be used only when oral phenytoin administration is not possible [see Dosage and Administration (2.4) and Warnings and Precautions (5.2)].",
    "contraindications_original": "\u2022 The dose, concentration, and infusion rate of CEREBYX should always be expressed as phenytoin sodium equivalents (PE) ( 2.1 ) \u2022 For Status Epilepticus: o Adult loading dose is 15 to 20 mg PE/kg at a rate of 100 to 150 mg PE/min ( 2.3 ) o Pediatric loading dose is 15 to 20 mg PE/kg at a rate of 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower) ( 2.3 ) \u2022 For Non-emergent Loading and Maintenance Dosing: o Adult loading dose is 10 to 20 mg PE/kg given IV or IM; initial maintenance dose is 4 to 6 mg PE/kg/day in divided doses ( 2.4 ) o Pediatric loading dose is 10 to 15 mg PE/kg at a rate of 1 to 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower); initial maintenance dose is 2 to 4 mg PE/kg every 12 hours at a rate of 1 to 2 mg PE/kg/min (or 100 mg PE/min, whichever is slower) ( 2.4 ) \u2022 Intramuscular Administration: o CEREBYX should ordinarily not be given intramuscularly ( 2.3 , 2.4 )",
    "adverseReactions_original": "CEREBYX is contraindicated in patients with:\n                  \n                     \n                        \u2022A history of hypersensitivity to CEREBYX or its inactive ingredients, or to phenytoin or other hydantoins [see Warnings and Precautions (5.6)]. Reactions have included angioedema.\n                     \n                        \u2022Sinus bradycardia, sino-atrial block, second and third degree A-V block, or Adams-Stokes syndrome because of the effect of parenteral phenytoin or CEREBYX on   ventricular automaticity.\n                     \n                        \u2022A history of prior acute hepatotoxicity attributable to CEREBYX or phenytoin [see Warnings and Precautions (5.8)].\n                     \n                        \u2022Coadministration with delavirdine because of the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors.",
    "drug": [
        {
            "name": "CEREBYX",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5165"
        }
    ]
}